Terms: = Liver cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Prognosis
23 results:
1. Role of miR
Cao Z; Zeng L; Wang Z; Zhou Y; Qian K
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1281-1295. PubMed ID: 38044639
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of prognosis of patients with hepatocellular carcinoma based on immune-related score.
Song XQ; Li RJ; Zhang S
Asian J Surg; 2024 Jan; 47(1):310-319. PubMed ID: 37673742
[TBL] [Abstract] [Full Text] [Related]
3. [The clinical value of serum GPC3 level in predicting recurrence of patients with primary hepatocellular carcinoma].
Zhang PR; Ma XL; Guo L; Lu RQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):885-890. PubMed ID: 37357208
[No Abstract] [Full Text] [Related]
4. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract] [Full Text] [Related]
5. Association of oral lichen planus with hepatic disorders and hepatocellular carcinoma: systematic review and meta-analysis.
González-Moles MÁ; de Porras-Carrique T; Ramos-García P
Med Oral Patol Oral Cir Bucal; 2023 May; 28(3):e229-e237. PubMed ID: 36806023
[TBL] [Abstract] [Full Text] [Related]
6. Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma.
Zhu P; Zhang F; Deng W; Chen W
Medicine (Baltimore); 2022 Sep; 101(39):e30695. PubMed ID: 36181094
[TBL] [Abstract] [Full Text] [Related]
7. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
8. Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma.
Wen S; Chen Y; Hu C; Du X; Xia J; Wang X; Zhu W; Wang Q; Zhu M; Chen Y; Shen B
Front Immunol; 2021; 12():788640. PubMed ID: 35095864
[TBL] [Abstract] [Full Text] [Related]
9. [Study on the prognostic value of preoperative anti hepatitis B virus therapy in patients with hepatocellular carcinoma complicated with microvascular tumor thrombus and establishment of survival prediction model].
Zhang L; Yang JR; Xia L; Chen HQ; Chen XL; Qian XJ; Li YX; Yang JW; Hu XQ; Peng WW; Pan WD
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2203-2209. PubMed ID: 34333932
[No Abstract] [Full Text] [Related]
10. Development and Evaluation of Nomograms to Predict the cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma.
Ni X; Li D; Dai S; Pan H; Sun H; Ao J; Chen L; Kong H
Biomed Res Int; 2021; 2021():1658403. PubMed ID: 33860031
[TBL] [Abstract] [Full Text] [Related]
11. Research on Early Warning Mechanism and Model of liver cancer Rehabilitation Based on CS-SVM.
Jianzhu B; Shuang L; Pengfei M; Yi Z; Yanshu Z
J Healthc Eng; 2021; 2021():6658776. PubMed ID: 33520150
[TBL] [Abstract] [Full Text] [Related]
12. Integrative analysis of the characteristics of lipid metabolism-related genes as prognostic prediction markers for hepatocellular carcinoma.
Zhu P; Li FF; Zeng J; Tang DG; Chen WB; Guo CC
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):116-126. PubMed ID: 33506899
[TBL] [Abstract] [Full Text] [Related]
13. Integrating Machine Learning and Tumor Immune Signature to Predict Oncologic Outcomes in Resected Biliary Tract cancer.
Ji GW; Wang K; Xia YX; Wang JS; Wang XH; Li XC
Ann Surg Oncol; 2021 Jul; 28(7):4018-4029. PubMed ID: 33230745
[TBL] [Abstract] [Full Text] [Related]
14. Impact of Site-Specific Metastases on Surgical Value and Survival among Metastatic Colorectal cancer Patients.
Zong Z; Zhou TC; Tang FX; Tian HK; Wang A; Yi CH
Am Surg; 2020 Mar; 86(3):220-227. PubMed ID: 32223801
[TBL] [Abstract] [Full Text] [Related]
15. [Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].
Zhang J; Chen J; Guan GW; Zhang T; Lu FM; Chen XM
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):402-408. PubMed ID: 31209409
[TBL] [Abstract] [Full Text] [Related]
16. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and prognosis.
Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y
Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420
[TBL] [Abstract] [Full Text] [Related]
17. Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma.
Yeh CC; Goyal A; Shen J; Wu HC; Strauss JA; Wang Q; Gurvich I; Safyan RA; Manji GA; Gamble MV; Siegel AB; Santella RM
Ann Surg Oncol; 2017 Nov; 24(12):3788-3795. PubMed ID: 28593503
[TBL] [Abstract] [Full Text] [Related]
18. Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma.
Chen Z; Pu L; Gao W; Zhang L; Han G; Zhu Q; Li X; Wu J; Wang X
Oncotarget; 2017 Apr; 8(17):28959-28970. PubMed ID: 28415824
[TBL] [Abstract] [Full Text] [Related]
19. Predictive factors of long-term colorectal cancer survival after ultrasound-controlled ablation of hepatic metastases.
Hernández-Socorro CR; Saavedra P; Ramírez Felipe J; Bohn Sarmiento U; Ruiz-Santana S
Med Clin (Barc); 2017 Apr; 148(8):345-350. PubMed ID: 28073517
[TBL] [Abstract] [Full Text] [Related]
20. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.
Lu Z; Peng J; Wang Z; Pan Z; Yuan Y; Wan D; Li B
Med Oncol; 2016 Nov; 33(11):121. PubMed ID: 27722895
[TBL] [Abstract] [Full Text] [Related]
[Next]
